Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
SciSparc Ltd. (SPRC)
NASDAQ:SPRC
Holding SPRC?
Track your performance easily
SPRC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.21 - $14.22
Previous Close$0.23
Volume398.49K
Average Volume (3M)3.05M
Market Cap
$2.41M
Enterprise Value$128.10K
Total Cash (Recent Filing)$5.14M
Total Debt (Recent Filing)$76.00K
Price to Earnings (P/E)―
Beta2.76
Next Earnings
Jul 05, 2019EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.87
Shares Outstanding2,703,674
10 Day Avg. Volume416,147
30 Day Avg. Volume3,052,815
Standard Deviation0.26
R-Squared0.04
Alpha-0.11
Financial Highlights & Ratios
Price to Book (P/B)0.09
Price to Sales (P/S)0.22
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.06
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
SciSparc Ltd. News
PremiumCompany Announcements
SciSparc Ltd. Reports Changes in Financial Position
PremiumCompany Announcements
SciSparc Ltd. Gains Shareholder Approval for Proposals
PremiumCompany Announcements
SciSparc Ltd. Reschedules Annual General Meeting
PremiumCompany Announcements
SciSparc Ltd. Proposes Reverse Stock Split
PremiumCompany Announcements
SciSparc Announces Intent to Sell MitoCareX Stake
PremiumCompany Announcements
SciSparc Advances Tourette Syndrome Drug TrialOwnership Overview
―
Insiders
―
Mutual Funds
― Other Institutional Investors
100.00% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
SPRC FAQ
What was SciSparc Ltd.’s price range in the past 12 months?
SciSparc Ltd. lowest stock price was $0.20 and its highest was $14.22 in the past 12 months.
What is SciSparc Ltd.’s market cap?
Currently, no data Available
When is SciSparc Ltd.’s upcoming earnings report date?
SciSparc Ltd.’s upcoming earnings report date is Jul 05, 2019 which is 1967 days ago.
How were SciSparc Ltd.’s earnings last quarter?
SciSparc Ltd. released its earnings results on Dec 03, 2018. The company reported -$0.012 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.012.
Is SciSparc Ltd. overvalued?
According to Wall Street analysts SciSparc Ltd.’s price is currently Overvalued.
Does SciSparc Ltd. pay dividends?
SciSparc Ltd. does not currently pay dividends.
What is SciSparc Ltd.’s EPS estimate?
SciSparc Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SciSparc Ltd. have?
SciSparc Ltd. has 10,357,108 shares outstanding.
What happened to SciSparc Ltd.’s price movement after its last earnings report?
SciSparc Ltd. reported an EPS of -$0.012 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of SciSparc Ltd.?
Currently, no hedge funds are holding shares in SPRC
---
SciSparc Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-94.72%
12-Months-Change
Fundamentals
Return on Equity
-103.20%
Trailing 12-Months
Asset Growth
5.96%
Trailing 12-Months
Company Description
SciSparc Ltd.
SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company operates in the single segment of the Development of drugs based on cannabinoid molecules to be approved by an official regulatory authority.
---
Technical Analysis
Relmada Therapeutics
―
SELLAS Life Sciences Group
―
Aptorum Group
―
Minerva Neurosciences
―
---